CCCC - CONSENSUS CO - C4 Therapeutics, Inc.

Market price action for C4 Therapeutics, Inc. (CCCC) on the GURU.Markets platform is 13.27. C4 Therapeutics, Inc. (CCCC) generates revenue by bringing targeted therapies to market, where the commercialization of TORPEDO system products will serve as the primary catalyst. Management is focused on implementing innovative protein degradation technology to combat tumors. However, the lack of its own profitable assets leaves the business dependent on tranches from third-party pharmaceutical counterparties.

A comparative analysis of average price target dynamics allows investors to assess the evolution of an asset's fundamental value relative to market noise. This metric aggregates expert expectations into a single trend, reflecting the growth potential of C4 Therapeutics, Inc. (CCCC) driven by the monopoly influence of Targetor technology on the inelastic oncology market, which is directly reflected in the consensus price target.